Respimat SMI
Sponsors
Boehringer Ingelheim
Conditions
Pulmonary Disease, Chronic Obstructive
Phase 3
Efficacy and Safety Comparison of Tiotropium Inhalation Solution (Respimat Inhaler) and Spiriva HandiHaler in COPD
CompletedNCT00239447
Start: 2002-11-26End: 2004-04-29Target: 131Updated: 2023-12-01
Efficacy and Safety Comparison of Tiotropium Inhalation Solution (Respimat Inhaler) and Spiriva HandiHaler in Chronic Obstructive Pulmonary Disease (COPD)
CompletedNCT00281567
Start: 2002-08-31Updated: 2013-11-01